A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
- Conditions
- Opiate Dependence
- Registration Number
- NCT01416584
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.
- Detailed Description
A randomized study is planned for 5 years to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and abstinence in unemployed injection drug users. Participants will be recruited through street outreach, at agencies that serve the target populations, and informal word-of-mouth referrals. Participants will be invited to attend the workplace and to enroll in the methadone treatment. To engage participants in the workplace, they will be allowed to work independent of whether they enroll in methadone treatment and independent of their drug use. The workplace participants (N=162) will be randomly assigned to three groups. The "Usual Care Control" participants will be allowed to work independent of their methadone use or urinalysis results. The "Methadone Contingency" participants will be required to take methadone to attend work, and will receive a brief pay decrease for failing to take their medication. The "Methadone \& Abstinence Contingency" participants will be required to take their medication in order to attend work, as well as receive a brief pay decrease for any positive urine samples for both cocaine and methadone.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percentage of Months in Methadone Treatment 6 months The percentage of months in which participants were enrolled in methadone treatment during the 6-month intervention evaluation period?
Percentage of Monthly Urine Sample Negative for Opiates 6 months Percentage of urine sample negative for opiates at each of the six 30-day assessments scheduled throughout the intervention evaluation
Percentage of Monthly Urine Samples Negative for Cocaine 6 months Was the participant's urine sample negative for cocaine at each of the six 30-day assessments scheduled throughout the intervention evaluation period?
- Secondary Outcome Measures
Name Time Method Percentage of M,W,F Urine Samples Negative for Cocaine 6 months Was each participant's urine sample negative for cocaine at each of the Monday, Wednesday, Friday urine samples scheduled throughout the intervention evaluation period?
Percentage of M,W,F Urine Samples Negative for Opiates 6 months Was each participant's urine sample negative for opiates at each of the Monday, Wednesday, Friday urine samples scheduled throughout the intervention evaluation period?
Trial Locations
- Locations (1)
Center for Learning and Health, Johns Hopkins Bayview Medical Campus, 5200 Eastern Ave., Suite W142
🇺🇸Baltimore, Maryland, United States
Center for Learning and Health, Johns Hopkins Bayview Medical Campus, 5200 Eastern Ave., Suite W142🇺🇸Baltimore, Maryland, United States